Diabetic neuropathy and oxidative stress
dc.contributor.author | Pop-Busui, Rodica | en_US |
dc.contributor.author | Sima, Anders A. F. | en_US |
dc.contributor.author | Stevens, Martin J. | en_US |
dc.date.accessioned | 2007-01-17T15:54:50Z | |
dc.date.available | 2007-01-17T15:54:50Z | |
dc.date.issued | 2006 | en_US |
dc.identifier.citation | Pop-Busui, Rodica; Sima, Anders; Stevens, Martin (2006)."Diabetic neuropathy and oxidative stress." Diabetes/Metabolism Research and Reviews 9999(9999): n/a-n/a. <http://hdl.handle.net/2027.42/49300> | en_US |
dc.identifier.issn | 1520-7552 | en_US |
dc.identifier.issn | 1520-7560 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/49300 | |
dc.description.abstract | This review will focus on the impact of hyperglycemia-induced oxidative stress in the development of diabetes-related neural dysfunction. Oxidative stress occurs when the balance between the production of reactive oxygen species (ROS) and the ability of cells or tissues to detoxify the free radicals produced during metabolic activity is tilted in the favor of the former. Although hyperglycemia plays a key role in inducing oxidative stress in the diabetic nerve, the contribution of other factors, such as endoneurial hypoxia, transition metal imbalances, and hyperlipidemia have been also suggested. The possible sources for the overproduction of ROS in diabetes are widespread and include enzymatic pathways, auto-oxidation of glucose, and mitochondrial superoxide production. Increase in oxidative stress has clearly been shown to contribute to the pathology of neural and vascular dysfunction in diabetes. Potential therapies for preventing increased oxidative stress in diabetic nerve dysfunction will be discussed. Copyright © 2006 John Wiley & Sons, Ltd. | en_US |
dc.format.extent | 400823 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | John Wiley & Sons, Ltd. | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Diabetes and Clinical Endocrinology | en_US |
dc.title | Diabetic neuropathy and oxidative stress | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA ; Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA. | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA ; Department of Internal Medicine, University of Birmingham, UK | en_US |
dc.contributor.affiliationother | Department of Pathology, Wayne State University, Detroit, MI, USA | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/49300/1/899_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/dmrr.625 | en_US |
dc.identifier.source | Diabetes/Metabolism Research and Reviews | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.